Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.5860
-0.1686 (-22.34%)
At close: Oct 14, 2026, 4:00 PM EDT
0.6028
+0.0168 (2.87%)
After-hours: Oct 14, 2026, 7:44 PM EDT
Rein Therapeutics Employees
Rein Therapeutics had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year. That makes Rein Therapeutics the 40,257th largest employer in the world and 6,108th in the United States.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
n/a
Profits / Employee
-$4,976,100
Market Cap
50.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -1 | -9.09% |
| Dec 31, 2024 | 11 | -4 | -26.67% |
| Dec 31, 2023 | 15 | 9 | 150.00% |
| Dec 31, 2022 | 6 | -3 | -33.33% |
| Dec 31, 2021 | 9 | 1 | 12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| XBiotech | 87 |
| Fortress Biotech | 78 |
| MindWalk Holdings | 77 |
| Verrica Pharmaceuticals | 76 |
| Oncolytics Biotech | 29 |
| Spero Therapeutics | 25 |
| Gain Therapeutics | 21 |
RNTX News
- 4 weeks ago - Rein Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Rein Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Rein Therapeutics Slides: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Filings
- 5 weeks ago - Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress - GlobeNewsWire
- 5 weeks ago - Rein Therapeutics to Present at Upcoming September Investor Conferences - GlobeNewsWire
- 7 weeks ago - Rein Therapeutics granted Fast Track designation for LTI-03 - TheFly
- 7 weeks ago - Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 1 month ago - Rein Therapeutics Slides: Corporate presentation - Filings